The WEB-RADR Team has published ‘Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR’ in Drug Safety.
Please click here for the paper: Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR
Key points:
|
A mobile application (app) designed for adverse drug reaction (ADR) reporting and product safety alerts can help to augment pharmacovigilance activities and extend a health authority’s reach to patients and healthcare professionals. |
|
Of particular value to app users was the ability to learn about the safety profiles of medicines through user-friendly, interactive graphics within the app as well as privacy and data protection features. |
|
While uptake and use of the app to date seems modest in comparison with other ADR-reporting modalities, it is reasonable to expect that app-based reporting will grow in importance as a younger generation of app-literate patients matures and smartphone owners increasingly use their mobile devices to access the Internet. |